ArticleJournal of medicinal chemistry2025

CD160-Derived Peptide as a Bidirectional Inhibitor Toward Immune Checkpoints BTLA/HVEM and HVEM/LIGHT.

Magdalena Lipińska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.